6WagsteinF.Eficacy of beta blockers in idiopathic dilated cardiomyopath y and ischemic cardiomyopathy.Am J Cardiol,1997,80(9B):45～49.
二级参考文献7
1Waagestein F,Bristow MR,Swedberg K,et al.Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy[].The Lancet.1993
2Fisher ML,Gottlieb SS,Plotnick GD,et al.Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial[].Journal of the American College of Cardiology.1994
3Gristow MR.Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents[].The American Journal of Cardiology.1993
4Eichhorn EJ,Heesch CM,Risser RC,et al.Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol[].Journal of the American College of Cardiology.1995
5Barnett DB.Beta-blockers in heart failure: a therapeutic paradox[].The Lancet.1994
6Waagestein F,Hjalmarson A,Varnauskas E.Effect of chronic betaadrenergic receptor blokade in congestive cardiomyopathy[].British Heart Journal.1975
7.The CIBIS Scientific Committee:Design of the Cardiac InsufficiencyBisoprolol Study (CIBIS )[].Fundamental and Clinical Pharmacology.1997
